Cancer stem cells are new vistas for predicting the course of breast cancer

Cancer stem cells are new vistas for predicting the course of breast cancer

Despite progress in treating breast cancer (BC) using a combined approach in view of morphological findings, distant metastases may develop in 30–90 % of patients with primary BC even at its early stages. The cancer stem cell (CSC) theory is one of the versions that could at least partially explain...

Full description

Bibliographic Details
Main Authors:	E. A. Maslyukova, S. I. Zabroda, L. I. Korytova, K. M. Pozharissky, G. A. Raskin, O. V. Korytov
Format:	Article
Language:	Russian
Published:	ABV-press 2015-09-01
Series:	Опухоли женской репродуктивной системы
Subjects:	рак молочной железы стволовые опухолевые клетки aldh1 резистентность к химиотерапии резистентность к лучевой терапии
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/442

Similar Items

Causes of resistance to PARP inhibitors and ways to overcome it. Case report of aggressive <i>BRCA</i>-related breast cancer
by: A. I. Stukan, et al.
Published: (2022-05-01)

Signs of apoptosis in circulating tumor cell subpopulations with phenotypes associated with stemness and epithelial-mesenchymal transition in breast carcinoma
by: V. M. Perelmuter, et al.
Published: (2022-12-01)

Blood levels of growth and progression factors in patients with locally advanced breast cancer during neoadjuvant chemotherapy
by: E. M. Frantsiyants, et al.
Published: (2021-09-01)

CXCR4 EXPRESSION IN DIFFERENT SUBSETS OF CTCs AND SINGLE (DETACHED) BREAST CANCER CELLS
by: O. E. Savelieva, et al.
Published: (2018-09-01)

On the role of autophagy in the progression of differentiated thyroid cancer (literature review)
by: K. A. Garipov, et al.
Published: (2022-01-01)

ROLE OF MORPHOLOGICAL AND GENETIC STRUCTURAL CHARACTERISTICS OF ESTROGEN RECEPTOR ALPHA IN THE DEVELOPMENT OF RESISTANCE TO ENDOCRINOTHERAPY WITH TAMOXIFEN IN PATIENTS WITH LUMINAL BREAST CANCER
by: Е. М. Slonimskaya, et al.
Published: (2016-02-01)

The overview of modern approaches in treatment of triple negative breast cancer
by: A. A. Kharitonova, et al.
Published: (2020-03-01)

COMPARATIVE ANALYSIS OF THE EXOSOMAL CARGO OF THE ESTROGEN-RESISTANT BREAST CANCER CELLS
by: S. E. Semina, et al.
Published: (2018-09-01)

The clinical significance of breast cancer stem cells (review of literature)
by: I. B. Schepotin, et al.
Published: (2014-11-01)

PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS
by: B. I. Kantemirova, et al.
Published: (2021-05-01)

Use of tofacitinib in real clinical practice to treat patients with rheumatoid arthritis resistant to synthetic and biological disease-modifying antirheumatic drugs: Results of a multicenter observational study
by: D. E. Karateev, et al.
Published: (2016-09-01)

EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT
by: S. G. Smirnova, et al.
Published: (2020-09-01)

ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2
by: E. V. Gorjacheva, et al.
Published: (2016-01-01)

Exosomes and development of cancer cell resistance to metformin: pilot study
by: S. E. Semina, et al.
Published: (2017-10-01)

Circulating tumor cells in breast cancer: clinical and molecular parallels
by: A. V. Zyuzyukina, et al.
Published: (2021-09-01)

CHANGES IN DNA METHYLATION PROFILE IN TAMOXIFEN-RESISTANT MCF-7 SUBLINES
by: О. Е. Andreeva, et al.
Published: (2019-11-01)

MicroRNA-484 / Akt axis in the regulation of breast cancer cells sensitivity to antitumor drugs
by: O. E. Andreeva, et al.
Published: (2022-12-01)

Comparative analysis of acelerated and conventional radiotherapy regimens in complex treatment of localy advanced breast cancer
by: A. G. Zolotkov, et al.
Published: (2016-02-01)

Overall survival in colon cancer patients with different levels of circulating tumor cells and feasibility of enhancing its prognostic value
by: O. I. Kit, et al.
Published: (2022-09-01)

Dissimilar tumor cell populations in ascitic fluid of ovarian cancer patients
by: E. V. Kaigorodova, et al.
Published: (2020-04-01)

Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01)

THE PRESENCE OF VARIOUS POPULATIONS OF CIRCULATING TUMOR CELLS IN THE BLOOD OF BREAST CANCER PATIENTS BEFORE TREATMENT: ASSOCIATION WITH FIVE-YEAR METASTASIS-FREE SURVIVAL
by: E. V. Kaigorodova, et al.
Published: (2020-12-01)

The number of cancer stem cells in the tumor tissue and perifocal tissue of non-muscle invasive bladder cancer
by: L. I. Belyakova, et al.
Published: (2022-03-01)

Intercellular interactions and progression of hormonal resistance of breast cancer cells
by: S. E. Semina, et al.
Published: (2015-06-01)

EXOSOMES AND DEVELOPMENT OF TUMOR CELL RESISTANT PHENOTYPE
by: M. A. Krasilnikov, et al.
Published: (2018-05-01)

RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: D. H. Aynetdinova, et al.
Published: (2015-12-01)

Resistance of breast cancer cells to all-trans retinoic acid is associated with a decrease in the basal level of nuclear receptor <i>RARα</i> expression and induction of cytochrome <i>CYP26A1</i> and <i>CYP26B1</i> expression
by: A. D. Enikeev, et al.
Published: (2022-06-01)

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER
by: E. N. Imyanitov, et al.
Published: (2017-12-01)

FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER
by: A. B. Sagakyants, et al.
Published: (2021-03-01)

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

Treatment of patients with bone marrow metastases: the present state of the problem
by: S. P. Kozlovskaya, et al.
Published: (2016-06-01)

MicroRNA: sex steroids, hormonal carcinogenesis, hormonal sensitivity of tumor tissue
by: A. V. Malek, et al.
Published: (2015-06-01)

THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS AFTER CORONARY STENTING IN PATIENTS WITH UNSTABLE ANGINA AND RESISTANCE TO ANTIPLATELET AGENTS
by: E. A. Medvedeva, et al.
Published: (2017-12-01)

Child morbidity of salmonellosis and the level of resistance of clinical isolates of salmonella to antibacterial preparations in saint Petersburg
by: N. V. Gonchar, et al.
Published: (2015-04-01)

The specific features of T cell immunity in breast cancer
by: L. V. Skotarenko, et al.
Published: (2014-08-01)

Prognostic value of receptor activator of nuclear factor kappa-B (RANK) marker in patients with breast cancer
by: S. I. Zabroda, et al.
Published: (2015-07-01)

Antimicrobial susceptibility of dominant Salmonella serovars, isolated in North-West federal district in 2004–2018 from different sourses
by: A. V. Zabrovskaia, et al.
Published: (2022-04-01)

Estrogen-dependent signaling pathways and their role in the tumor progression: progress and perspectives
by: M. A. Krasil’nikov, et al.
Published: (2015-06-01)

Molecular genetic aspects of prostate cancer radioresistance
by: E. P. Omelchuk, et al.
Published: (2021-10-01)

Eradication of Helicobacter Pylori
by: V. V. Tsukanov, et al.
Published: (2015-12-01)